A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
Titel:
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
Auteur:
Povsic, Thomas J. Junge, Candice Nada, Adel Schatz, Richard A. Harrington, Robert A. Davidson, Charles J. Fortuin, F. David Kereiakes, Dean J. Mendelsohn, Farrell O. Sherman, Warren Schaer, Gary L. White, Christopher J. Stewart, Duncan Story, Kenneth Losordo, Douglas W. Henry, Timothy D.